…s (SSc) is associated with significant morbidity and mortality. Pulmonary arterial hypertension (PAH) represents a negative prognostic factor, with a 3-year survival…
PAH
This disease is selected. Its supporting articles are shown below.
Articles mentioning PAH
22 articles · page 2 of 2… Vasodilators, at least on monotherapy, should be considered in PVOD/PAH, as they seem to be well tolerated. Nevertheless, at follow…
…artery hypertension (PAH): 8%, digital ulcer history (DU): 52%, myositis: 13%). The median (SD) Raynaud’s phenomenon and SSc-disease dur…
…Introduction Calcinosis cutis is a disabling complication of systemic sclerosis (SSc) with gl…
…ongitudinal variations.Material and Methods Adult patients with systemic sclerosis (SSc) from Maccabi Healthcare Services (MHS), a 2.7-million-mem…
…l lung disease (ILD) and potential benefits on skin fibrosis in systemic sclerosis (SSc). This study aims to evaluate the safety and effectiveness of TC…
…Background Comorbidities add complexity to pulmonary arterial hypertension (PAH), but also open opportunities to use therapies with benefi…
…Introduction A key challenge in pulmonary arterial hypertension (PAH) research is assessing the specific impact of this conditi…
…ed congenital heart disease characterised by the development of pulmonary arterial hypertension (PAH) due to chronic left-to-right shunting. Despite the increasing u…
…Introduction Pulmonary arterial hypertension (PAH) is an umbrella term describing a group of diseases charac…